abstract |
The present invention relates to antisense oligonucleotide, its regulation lipid transfer and the expression of metabolic gene and/or function, especially by targeting lipids transhipment and the natural antisense polynucleotide of metabolic gene.The present invention also relates to the qualification of these antisense oligonucleotides and the application in treating the disease relevant with lipid transfer and Metabolic Gene Expression and disease thereof. |